Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19

A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the cause of coronavirus disease 2019 (COVID-19). It emerged in China in 2019 and has since spread worldwide. COVID-19 has a wide spectrum of clinical scenarios, ranging from totally asymptomatic to death. Preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarabel, Lucia, Guardascione, Michela, Dal Bo, Michele, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816887/
https://www.ncbi.nlm.nih.gov/pubmed/33476760
http://dx.doi.org/10.1016/j.ijid.2021.01.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816887/
https://www.ncbi.nlm.nih.gov/pubmed/33476760
http://dx.doi.org/10.1016/j.ijid.2021.01.035

Ejemplares similares